Breast Cancer Clinical Trial
Assessing Functional Status Needs Via PRO Measures for Pts With Metastatic Breast Cancer
Summary
The purpose of this single-site non-randomized study is to identify areas of need related to functional status and overall health, including nutrition and mental health in subjects with metastatic breast cancer (MBC). A decline in functional status is observed after breast cancer diagnosis and exacerbated by treatment. Declining functional status impacts the quality of life and can lead to increased comorbidity burden, hospitalization, and increased mortality. Functional status is assessed by specific provider-graded scales. Patient Reported Outcome (PRO) measures may better assess certain aspects of patient health and symptom domains. Thus, potentially supporting the future implementation of effective prehabilitation strategies. This study explores whether a PRO-based survey will identify the physical and emotional health and the social and financial status of patients newly diagnosed with MBC.
Eligibility Criteria
In order to participate in this study a subject must meet all of the eligibility criteria outlined below.
Inclusion Criteria:
Written informed consent was obtained from participants in the study and HIPAA authorization for release of personal health information.
Subject is willing and able to comply with study procedures based on the judgment of the investigator or protocol designee.
Age ≥ 18 years at the time of consent.
Recent diagnosis of new metastatic breast cancer at time of screening.
Exclusion Criteria:
Exclusion Criteria
Inability to read or speak English.
Dementia, altered mental status, or any psychiatric condition as determined by clinical or study team that would prohibit the understanding or rendering of informed consent.
Current incarceration.
Subject has already received treatment for metastatic breast cancer prior to screening.
Check Your Eligibility
Let’s see if you might be eligible for this study.
What is your age and gender ?
There is 1 Location for this study
Chapel Hill North Carolina, 27599, United States
How clear is this clinincal trial information?